American Association for Clinical Chemistry
Job Title* Country* Read more
Category: Clinical Research/Diagn.
Uman Diagnostics and Bio-Techne Announce License and Supply Agreement for Neurofilament Light Assay
JULY 23, 2019 MINNEAPOLIS, July 23, 2019 /PRNewswire/ — Uman Diagnostics, now part of Quanterix, and Bio-Techne announced today a strategic License and Supply Agreement for the antibodies used in the quantification of neurofilament light (Nf-L) on the ProteinSimple™-branded Ella™ immunoassay platform. Under the terms of the agreement, Uman Diagnostics will supply Nf-L antibodies to Bio-Techne... Read more
Roche expands the Global Access Program beyond HIV to also include diagnostic tests for Tuberculosis, Hepatitis, and Human Papillomavirus
Basel, 22 July 2019 Roche expands the Global Access Program beyond HIV to also include diagnostic tests for Tuberculosis, Hepatitis, and Human Papillomavirus Access to innovative diagnostic solutions will contribute to the World Health Organization’s infectious disease elimination goals Improving access to reliable diagnostics for disease management in countries with the highest burden Early detection... Read more
Ontera Welcomes Dr. J. Wallace Parce to Its Advisory Board
July 17, 2019 07:30 AM Eastern Daylight Time SANTA CRUZ, Calif.–(BUSINESS WIRE)–Ontera, the leader in silicon-based nanopore diagnostics, today announced the appointment of Dr. J. Wallace (Wally) Parce to its Advisory Board. Dr. Parce comes to Ontera as a respected and successful serial entrepreneur in life science technology development and commercialization. He was Co-Founder, Vice... Read more
Abcam Enters Cell Editing Market Through Acquisition of EdiGene’s Knock-out Cell Lines and Lysates Portfolio
Largest off-the-shelf diploid KO library, over 2,800 cell lines Cambridge, UK and Beijing, CN: 16 July, 2019 – Abcam plc, a global innovator in life science reagents and tools, is today pleased to announce the acquisition of the entire live cell line and lysates portfolio of EdiGene Inc, a leading company focused on developing genome editing... Read more
NanoString Collaborates with MODEL-AD Consortium to Accelerate Alzheimer’s Disease Research
nCounter Mouse AD Gene Expression Panel Applied to Characterize Five Novel Mouse Models New nCounter Human AD Gene Expression Panel Launched at AAIC 2019 SEATTLE, July 15, 2019 (GLOBE NEWSWIRE) — NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced a collaboration with the MODEL-AD consortium that has resulted in... Read more
Expanding Business and Capital Alliance Contract with HEALIOS K.K. to develop practical applications for regenerative medicine
July 10, 2019 TOKYO – Nikon Corporation (Nikon) agreed on the expansion of partnership between HEALIOS K.K. (Hardy TS Kagimoto, CEO, Tokyo, Japan, hereafter referred to as Healios) based on the business and capital alliance agreement concluded in 2017. Based on this agreement, Nikon will accept 4 billion yen of series 2 unsecured convertible bonds... Read more
PerkinElmer Launches CE-Marked Infectious Disease Immunoassays on EUROIMMUN Random Access Instrument
ChLIA-based tests for detection of antibodies against Borrelia and Epstein-Barr Virus now available on EUROIMMUN RA Analyzer 10 System WALTHAM, Mass. – July 10, 2019 – PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced the first two CE-marked chemiluminescence immunoassays (ChLIA) for the detection of anti-Borrelia (Lyme disease) and... Read more
Bruker Announces Acquisition of Preclinical and Molecular Imaging Research Software Provider PMOD Technologies LLC
Acquisition strengthens Bruker’s portfolio of high-performance PET molecular imaging solutions ZURICH, Switzerland, July 8, 2019 /PRNewswire/ — Bruker today announced that it has acquired PMOD Technologies LLC, a highly respected provider of research-use-only software for preclinical and molecular imaging, with a focus on molecular quantification and pharmacokinetic modeling. The PMOD software is widely used for... Read more
Century Therapeutics Launches with $250M Financing for iPSC Allogeneic Cell Therapy Platform
Tokyo, June 1, 2019 ― FUJIFILM Corporation (President: Kenji Sukeno) will accelerate the development of next-generation cancer immunotherapeutic drug candidates by harnessing the self-renewal potential of allogenic induced pluripotent stem cells (iPSCs). FUJIFILM Cellular Dynamics, Inc. (FCDI), a leading developer and manufacturer of human iPSCs and tissue-specific cells differentiated from iPSCs, and Versant Venture Management,... Read more